Language: BG BG
← Back to results
Recruiting NCT06974305

PET/MRI/EEG Imaging Study in Epilepsy

Conditions: Epilepsy

Sponsor: Massachusetts General Hospital

trial.available_in: БГ
Overview
This study aims to better understand how epilepsy alters brain function through neuroimaging of healthy people and people with epilepsy. The study investigates how changes in brain metabolism (sugar consumption, measured by positron emission tomography \[FDG-PET\], and blood flow, measured by functional magnetic resonance imaging \[fMRI\]) relate to abnormal interictal electrical activity associated with epilepsy (measured by electroencephalography \[EEG\]). The study will also compare how the three imaging modalities localize regions of abnormal function in the brain.
Who can participate
Inclusion Criteria: * Age 18 or older Additional Inclusion Criteria for Subjects with Epilepsy: * Diagnosed with epilepsy with abnormal interictal EEG Exclusion Criteria: * Contraindications to PET, MRI, or EEG imaging * History of severe brain disease such as stroke and head trauma * History of brain surgery * History of type I or II diabetes mellitus * Fasting plasma glucose level \>200 mg/dL * Employed under direct supervision of the PI conducting the research Additional Exclusion Criteria for Healthy Subjects: * Current use of drugs that modulate brain function * Current or past history of major medical, neurological, or psychiatric conditions
Interventions
FDG-PET/fMRI/EEG imaging
RADIATION
Locations 1
United States (1)
Athinoula A. Martinos Center
Charlestown , Massachusetts
Technical details
Status
Recruiting
Study type
OBSERVATIONAL
Sex
Male and female
Minimum age
18 Years
Healthy volunteers
No
Start date
21.09.2023
Completion date
31.12.2026
Registry ID
NCT06974305
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.